{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:34:43Z","timestamp":1791048883042,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.neurobiolaging.2005.08.010","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T14:22:59Z","timestamp":1128435779000},"page":"1431-1434","source":"Crossref","is-referenced-by-count":37,"title":["Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Omanma","family":"Adighibe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampath","family":"Arepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Wavrant-De Vri\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI9794","article-title":"Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice","volume":"107","author":"Alberti","year":"2001","journal-title":"J Clin Invest"},{"issue":"Spec No 1","key":"10.1016\/j.neurobiolaging.2005.08.010_bib2","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1093\/hmg\/ddh077","article-title":"Alzheimer's disease: one disorder, too many genes?","volume":"13","author":"Bertram","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.08.010_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddg007","article-title":"Results of a high-resolution genome screen of 437 Alzheimer's disease families","volume":"12","author":"Blacker","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib4","doi-asserted-by":"crossref","first-page":"34674","DOI":"10.1074\/jbc.M402324200","article-title":"Differential expression of cholesterol hydroxylases in Alzheimer's disease","volume":"379","author":"Brown","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.08.010_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0304-3940(02)00703-6","article-title":"Possible association between genetic variability at the apolipoprotein(a) locus and Alzheimer's disease in apolipoprotein E2 carriers","volume":"331","author":"Compton","year":"2002","journal-title":"Neurosci Lett"},{"issue":"5123","key":"10.1016\/j.neurobiolaging.2005.08.010_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0039-128X(03)00100-4","article-title":"Transcriptional regulation of farnesyl pyrophosphate synthase by liver X receptors","volume":"68","author":"Fukuchi","year":"2003","journal-title":"Steroids"},{"issue":"50","key":"10.1016\/j.neurobiolaging.2005.08.010_bib8","doi-asserted-by":"crossref","first-page":"48508","DOI":"10.1074\/jbc.M209085200","article-title":"Induction of cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonist increases secreted A\u03b2 levels","volume":"277","author":"Fukumoto","year":"2002","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2005.08.010_bib9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case\u2013control study","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/8.2.237","article-title":"A full genome scan for late onset Alzheimer's disease","volume":"8","author":"Kehoe","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2005.08.010_bib11","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M411420200","article-title":"The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease","volume":"280","author":"Koldamova","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib12","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1074\/jbc.M300044200","article-title":"22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion","volume":"278","author":"Koldamova","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2005.08.010_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neulet.2004.05.047","article-title":"Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case\u2013control study","volume":"366","author":"Li","year":"2004","journal-title":"Neurosci Lett"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2005.08.010_bib14","first-page":"2037","article-title":"A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes","volume":"43","author":"Liang","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1194\/jlr.M100358-JLR200","article-title":"LXR\/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells","volume":"43","author":"Murthy","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.10183","article-title":"Full genome screen for Alzheimer disease: stage II analysis","volume":"114","author":"Myers","year":"2002","journal-title":"Am J Med Genet (Neuropsychiatric Genet)"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.08.010_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/hmg\/ddh138","article-title":"The structure of tau haplotype in controls and in progressive supranuclear palsy","volume":"13","author":"Pittman","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2005.08.010_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","article-title":"Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease","volume":"26","author":"Poirier","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2005.08.010_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","article-title":"A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease","volume":"8","author":"Refolo","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib21","doi-asserted-by":"crossref","first-page":"27688","DOI":"10.1074\/jbc.M300760200","article-title":"Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion","volume":"278","author":"Sun","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/423393","article-title":"Evidence for a novel late-onset Alzheimer's disease locus on chromosome 19p13.2","volume":"75","author":"Wijsman","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.08.010_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0896-6273(03)00840-7","article-title":"Cholesterol and biology of Alzheimer's disease","volume":"41","author":"Wolozin","year":"2004","journal-title":"Neuron"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T19:50:41Z","timestamp":1548100241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458005002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0197458005002393"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.08.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}